Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers

Indian Journal of Experimental Biology

Volumn 52, Issue 7, 2014, Pages 720-727

  Niture, Netaji T ^a   Ansari, Ansar A ^a   Naik, Suresh R ^b  

^a SINHGAD COLLEGE OF PHARMACY   (India)

^b Sinhgad Institute of Pharmaceutical Sciences   (India)

Author keywords

Antidiabetic activity; Antioxidants; Lipid profile; Pro inflammatory cytokines; Rutin; Streptozotocin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; INSULIN; INTERLEUKIN 6; LIPID; PIOGLITAZONE; RUTOSIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DIABETES MELLITUS; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIPID DIET; MALE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; INTERLEUKIN-6; LIPIDS; MALE; MICE; RATS, SPRAGUE-DAWLEY; RUTIN; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903792466     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bhat M, Zingarde S S, Bhargava S Y, Kumar A R & Joshi B N, Antidiabetic Indian plants: a good source of potent amylase inhibitors, Evid Based Complent Alternat Med, 040 (2008) 1.
2. Srinivasan K, Patole P S, Kaul C L & Ramarao P, Reversal of glucose intolerance by pioglitazone in high-fat diet fed rats, Methods Find Exp Clin Pharmacol, 26 (2004) 327.
3. Zozulinska D & Wierusz-Wysocka, Type 2 diabetes mellitus as inflammatory disease, Diabetes Res Clin Pr, 74 (2006) S12.
4. Brownlee M, Biochemistry and molecular cell biology of diabetic complications, Nature, 414 (2001) 813.
5. Sjöholm D & Nyström T, Endothelial inflammation in insulin resistance, The Lancet, 365 (2005) 610.
6. Niehoff A G, van Haeften T W, Onland-Moret NCh, Elbers C C, Wijmenga C & van der Schouw Y T, C-reactive protein is independently associated with glucose but not with insulin resistance in healthy men, Diabetes Care, 30 (2007) 1627.
7. Marles R J & Farnsworth N R, Antidiabetic plants and their active constituents, Phytomedicine, 2 (1995) 137.
8. Martinello F, Soares S M, Franco J J, Santos A C, Sugohara A & Garcia S B, Hypolipidemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterolemic hamsters, Food Chem Toxicol, 44 (2006) 810.
9. Abdelmoaty M A, Ibrahim M A, Ahmed N S & Abdelaziz M A, Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats, Indian J Clin Biochem, 25 (2010) 188.
10. Kamalakkannan N & Prince P S, Antihyperglycemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats, Basic Clin Pharmacol Toxicol, 98 (2006) 97.
11. Srinivasan K, Partial protective effect of rutin on multiple low dose streptozotocin, Indian J Pharmacol, 37 (2005) 327.
12. Yildizoglu-Ari N, Altan V, Altinkurt O & Ozturk Y, Pharmacological effects of rutin, Phytother Res, 5 (1991) 19.
13. Nagasawa T, Tabata N, Ito Y, Aiba Y, Nishizawa N & Kitts D D, Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats, Mol Cell Biochem, 252 (2003) 141.
14. Srinivasan K, Viswanad B, Asrat L, Kaul C L, & Ramarao P, Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening, Pharmacol Res, 52 (2005) 313.
15. Trinder P, Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor, Ann Clin Biochem, 6 (1969) 24.
16. Alayash A I, El-Hassan A M, Omer R & Bonaventura J, Glycosylated hemoglobin: an indicator of long-term blood glucose in domestic sheep and goats, Comp Biochem Physiol, 90 (1988) 229.
17. El-Zayadi A, Insulin resistance, Arab J Gastroenterol, 11 (2010) 66.
18. Ohkawa H, Ohishi N & Yagi K, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal Biochem, 95 (1979) 351.
19. Beutler E, Duron O, Kelly B M, Improved method for the determination of blood glutathione, J Lab Clin Med, 61 (1963) 882.
20. Kono Y, Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase, Arch Biochem Biophys, 186 (1978) 189.
21. Claiborne A, Catalase activity, in CRS handbook of methods in oxygen radicals research, edited by R A Greenwald (CRS press: Boca Raton) 1985, 283.
22. Lowry O H, Rosebrough N J, Farr A L & Randall R J, Protein measurement with the Folinphenol reagent, J Biol Chem, 193 (1951) 265.
23. Sahin K, Onderci M & Tuzcu M, Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat, Metabolism, 56 (2007) 1233.
24. Mohammadi J & Naik P R, Evaluation of hypoglycemic effect of Morus alba in animal model, Indian J Pharmacol, 40 (2008) 15.
25. Moller D E, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab, 11 (2000) 212.
26. Chavez E & Henry R R, Type 2 diabetes: Insulin resistance, beta cell dysfunction, and other metabolic and hormonal abnormalities, in Clinical diabetes: Translating research into practice, edited by Fonseca, V.A. (WB Saunders Co, USA) 2005, 21.
27. Steinberg G R, Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance, Cell Cycle, 6 (2007) 888.
28. Mendivil C O & Sierra I D, Acción insulinica y resistencia a la insulina: aspectos moleculares. Revista de la Facultad de Medicina de la Universidad Nacional de Colombia, 53 (2005) 235.
29. Senn J J, Klover P J, Nowak I A, Zimmers T A, Koniaris L G, Furlanetto R W & Mooney R A, Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6 dependent insulin resistance in hepatocytes, J Biol Chem, 278 (2003) 13740.
30. Farmer E E & Davoine C, Reactive electrophile species, Curr Opin plant Biol, 10 (2007) 380.
31. Aksoy N, Vural H, Sabuncu T & Aksoy S, Effect of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats, Cell Biochem Funct, 21 (2003) 121.
32. Rauscher F M, Sanders R A & Watkins J B III, Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats, J Biochem Mol Tox, 15 (2001) 41.
33. Rosholt M N, King P A & Horton E S, High-fat diet reduces glucose transporter responses to both insulin and exercise, Am J Physiol Regul Integr Comp Physiol, 266 (1994) R 95.
34. Honjo K, Doi K, Doi C & Mitsuoka T, Histopathology of streptozotocin-induced diabetic DBA/2N and CD-1 mice, J Lab Anim, 20 (1986) 298.